Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

In Silico Anti-HIV Analysis of FTIR Identified Bioactive Compounds Present in Vitex altissima L and Vitex leucoxylon L


Affiliations
1 Department of Biotechnology, Vel Tech High Tech Dr. Rangarajan, Dr. Sakunthala Engineering College, Avadi, Chennai, India
2 Department of Bio Engineering, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai-600117, India
     

   Subscribe/Renew Journal


The knowledge of the traditional plants in India is a collection over millennia by our ancient people. The Siddha System of Medicine (Traditional Tamil System of medicine) is the foremost of all other medical systems in the world which provide service to the humanity for more than 5000 years in combating diseases and also in maintaining its physical, mental and moral health. Vitex species were used in Siddha for its antiviral activity for several years. However, the present study deals with the Human Immunodeficiency Virus because of its complexity and killing effects. FTIR analysis of Vitex altissima L and Vitex leucoxylon L revealed the presence of 21 and 17 bioactive compounds respectively. These compounds were analysed further for its binding affinity mechanism against one of the virulence causing protein, reverse transcriptase (target protein) of Human Immunodeficiency Virus (HIV) by using molecular docking and bioinformatics tools. Interaction rate was determined between bioactive compounds against the protein target based on binding free energy requirements. Molecular docking was also made to the commercially available drugs (Zidovudine, Stavudine, and Nevirapine) against the target protein. By comparing the results, it was clear that the bioactive compounds in the Vitex species were much more effective than the commercially available drugs, thereby suitable for the treatment of AIDS. Hence, this study will form the basis for promoting therapeutic lead molecules from the traditional plants which restore the tradition and also eliminates the harmful side effects.

Keywords

FTIR Analysis, Vitex altissima L, Vitex leucoxylon L, Zidovudine, Stavudine, Nevirapine, Binding Free Energy, Molecular Docking.
Subscription Login to verify subscription
User
Notifications
Font Size


  • A.B.D. Vaidya and T.P.A. Devasagayam, Journal of Clinical Biochemistry and Nutrition, vol. 41, pp. 1-11, 2007.

  • S.V. Subramanian, V.R. Madhaven (Eds), “Heritage of Tamil Siddha medicine”. (Madras, India: International Institute of Tamil Studies), pp. 171-184, 1983.

  • J. J Thas, Clinics in Dermatology, vol. 26, pp. 62-78, 2008.

  • X. Zhang, “Regulatory situation of herbal medicines – a worldwide review”, World Health Organization, Geneva, Switzerland. 1998. Available at: http://apps.who.int/medicinedocs/pdf/whozip57e/whozip57e.pdf (accessed on 25thMay 2012).

  • W. Sneader, “Drug Discovery: A History”, Chichester, UK: Wiley, 2005.

  • K. Karunamoorthi, K. Jegajeevanram, J. Xavier, J. Vijayalakshmi, L. Melita, “Tamil traditional medicinal system- Siddha: An indigenous health practice in the international perspectives”, TANG Humanitas Medicine, vol. 2(2), pp. 1-4, 2012.

  • T.V. Sambasivapillai, “Dictionary based on Indian medical science, Chennai, India: National Institute of Siddha”, 1931.

  • J.O. Kahn, B.D. Walker, “Acute human immunodeficiency virus type 1 infection”, N Engl J Med,vol. 339, pp. 33–39, 1998.

  • P.K. Mukherjee, A. Wahile, “Integrated approaches towards drug development from Ayurveda and other Indian system of medicines”, J Ethnopharmacol, vol. 103, pp. 25-35, 2006.

  • V. Narayanaswamy, “Introduction to the Siddha System of Medicine”, Madras, India: Research Institute of Siddha Medicine, 1975.

  • K. Padmalatha, K. Jayaram, N.L. Raju, M.N.V. Prasad and R. Arora, “Ethnopharmacological and Biotechnological Significance of Vitex”, Bioremediation, Biodiversity and Bioavailability, vol.3(1), pp. 6-14,2009.

  • A.K. Meena, U.S. Niranjan, M.M. Rao, M.M. Padhi, R. Babu, “A review of the important chemical constituents and medicinal uses of Vitex genus”, Asian Journal of Traditional Medicines, vol. 6(2), pp.54-60, 2011.

  • S. S. Sathish, N. Janakiraman, M. Johnson, “Phyto chemical analysis of Vitex alitssima L. Using UV-Vis, FTIR and GC-MS”, International Journal of Pharmaceutical Science and Drug Research, vol.4 (1), pp. 56-62, 2012.

  • J.A. Parrotta, “Healing plants of Peninsular India”, CABI Publishers, USA, pp. 770.

  • C. Sridhar, G.V. Subburaju, Y. Venkateshwaralu, R.T. Venugopal. “New acylatediridoid glycosides from Vitexaltissima”. Journal of Natural Products, Vol. 67, pp. 2012-2016, 2004.

  • C. Sridhar, K.V. Rao, G.V. Subburaju, “Flavonoids, triterpenoids and a lignin from Vitex altissima”. Phytochemistry, Vol. 66, pp. 1707-1712, 2005.

  • P.M. Pragada, G.M.N. Rao, “Ethno veterinary medicinal practices in tribal regions of Andhra Pradesh, India”. Bangl J Plant Taxon Vol. 19(1), pp. 7-16, 2012.

  • K.N. Reddy, C.S. Reddy, V.S Raju, “Ethnomedicinal observations among the Kondareddis of Khammam district, Andhra Pradesh, India”, Ethnobotanical Leaflets Vol. 12, pp. 916-926, 2008.

  • M. Ayyanar, S. Ignacimuthu, “Herbal medicines for wound healing among tribal people in Southern India: Ethnobotanical and scientific evidences”. International Journal of Applied Research in Natural Products, Vol. 2(3), pp. 29-42, 2009.

  • M.K.R. Narayanan, S. Mithunlal, P. Sujanapal, N. Anil Kumar, M. Sivadasan, A.H. Alfarhan, A.A. Alatar, “Ethnobotanically important trees and their uses by Kattunaikka tribe in Wayanad Wildlife Sanctuary, Kerala, India”. Journal of Medicinal Plants Research, Vol. 5(4), pp. 604-612, 2011.

  • N. Rajakumar, M.B. Shivanna, “Traditional herbal medicinal knowledge in Sagar taluk of Shimoga district, Karnataka, India”. Indian Journal of Natural Products and Resources, Vol. 1(1), pp. 102-108, 2010.

  • M. Ayyanar, S. Ignacimuthu, “Medicinal plants used by the tribals of Tirunelveli hills, Tamil Nadu to treat poisonous bites and skin diseases”. Indian J Trad Knowledge, vol. 4(3), pp. 229-236, 2005.

  • K. Narayana Rao, T. Thammanna, “Medicinal Plants of Tirumala. T.T.D, Tirupati, India”, 1990.

  • Y.R. Chanda, “The wealth of India: A dictionary of Indian Raw materials and Industrial products”, Publication and Information Directorate, CSIR, New Delhi, pp: 520-521, 1982. http://www.niscair.res.in/activitiesandservices/products/woi1.htm

  • H.G. Makwana, B. Ravishankar, V.J. Shukla, N.P. Vijayan, C.K. Sasikala, V.N. Saraswathy and S.V. Bhatt, “General pharmacology of Vitex leucoxylonlinn leaves”. Indian J. Physiol. Pharmacol, Vol. 38, pp. 95-100, 1994. http://indianmedicine.eldoc.ub.rug. nl/ischolar_main/M/65647/

  • S.P. Sarma, K.S. Aithal, K.K. Srinivasan, A.L. Udupa, V. Kumar, D.R. Kulkarni and P.K. Rajagopal, “Anti-inflammatory and wound healing activities of the crude alcoholic extract and flavonoids of Vitex leucoxylon”. Fitoterapia, vol. 61, pp. 263-265, 1990.

  • Goudsmit, Jaap, “Viral Sex; the Nature of AIDS”. Oxford University Press. New York, New York, pp. 51-58. Retrieved May 25, 2008.

  • D.D. Richman, “Antiviral drug resistance”. Antiviral Res, vol. 71, pp. 117-121, 2006.

  • P.D. Yin, D. Das, H. Mitsuya, “Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance”. Cell Mol Life Sci., Vol. 63, pp. 1706-1724, 2006.

  • R.W. Shafer, S.Y. Rhee, D. Pillay, V. Miller, P. Sandstrom, J.M. Schapiro, D.R. Kuritzkes, D. Bennett, “HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance”. AIDS, vol. 21, pp. 215-223, 2007.

  • Kaio Kitazato, Yifei Wang, Nobuyuki Kobayashi, “Viral infectious disease and natural products with antiviral activity”. Drug Discov Ther, Vol. 1(1), pp. 14-22, 2007.

  • F. DimarzoVeronese, D.T. Copeland, A.L. Devico, R. Rahman, S. Oroszlan, R.C. Gallo, M.G. Sarngadharan, “Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV”. Science, vol. 231(4743), pp. 1289–1291, 1986.

  • I.C. Bathurst, L.K. Moen, M.A. Lujan, H.L. Gibson, P.H. Feucht, S. Pichuantes, C.S. Craik, D.V. Santi, P.J. Barr, “Characterization of the human immunodeficiency virus type-1 reverse transcriptase enzyme produced in yeast”. Biochem. Biophys. Res. Commun., vol. 171, pp. 589-595, 1990.

  • E. De Clercq, “Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection”. Med Res Rev, vol. 20, pp. 323-349, 2000.

  • Y. Mel Safadi, V. Vivet-Boudou, R. Marquet R, “HIV-1 reverse transcriptase inhibitors”. Appl Microbiol Biotechnol, vol. 75, pp. 723-737, 2007.

  • M.J. Camarasa, S. Velázquez, A. San-Félix, M.J. Pérez-Pérez, F. Gago, “Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes”, Antiviral Res, vol. 71, pp. 260-267, 2006.

  • V. Nair, G. Chi, “HIV integrase inhibitors as therapeutic agents in AIDS”. Rev Med Viol (in press).

  • Y. Pommier, A.A. Johnson, C. Marchand, “Integrase inhibitors to treat HIV/AIDS”. Nat Rev Drug Discov, vol. 4, pp. 236-248, 2004.

  • B. Grinsztejn, B.Y. Nguyen, C. Katlama, J.M. Gatell, A. Lazzarin, D. Vittecoq, C.J. Gonzalez, J. Chen, C.M. Harvey, R.D. Isaacs, “Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomized controlled trial”. Lancet, vol. 369, pp. 1261-1269, 2007.

  • B.S. Min, M. Hattori, H.K. Lee, Y.H. Kim, “Inhibitory constituents against HIV-1 protease from Agastacherugosa”. Arch Pharm Res, vol. 22, pp. 22:75-77, 1999.

  • B.S. Min, H.J. Jung, J.S. Lee, Y.H. Kim, S.H. Bok, Ma C. M, Nakamura N, M. Hattori, K. Bae, “Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease”. Planta Med, vol. 65, pp. 374-375, 1999.

  • R.Ashokkumar and M. Ramaswamy, “Phytochemical screening by FTIR spectroscopic analysis of leaf extracts of selected Indian Medicinal plants”. Int.J.Curr.Microbiol.App.Sci., vol. 3(1), pp. 395-406, 2014.

  • Y. Hsiou, J. Ding, K. Das, A.D. Clark Jr., S.H. Hughes, Arnold. “Structure of unliganded HIV1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms”, E. Journal: (1996) Structure 4: 853-860.

  • Thangaraj, Sindhu, Sundaraj, Rajamanikandan, Dhanapal, Durgapriya, Jebamalai, Raj, Anitha, Selvaraj, Akila and Velliyur Kanniyapan, Gopalakrishnan. “Molecular Docking and Qsar Studies On Plant Derived Bioactive Compounds as Potent Inhibitors of Dek Oncoprotein”. Asian Journal of Pharmaceutical and Clinical Research, vol. 4(2), 2011; ISSN-0974-2441.

  • K. Rohini, P.S. Srikumar, “In Silico Approach of Anticancer Activity of Phytochemical Coumarins against Cancer Target Jnks”. International Journal of Pharmacy and Pharmaceutical Sciences, ISSN- 0975-1491.Vol 5, Suppl 3, 2013.

  • K.V. Lisina, Eashwaran Murugesh, Shanmughavel Piramanayagam. “In Silico Analysis of Compounds Characterized from Nymphaea stellata Flower with MUC1”. Int. J. Pharm. Sci. Rev. Res., vol. 23(2), Nov – Dec 2013; pp. 180-184. ISSN 0976–044X.

  • Ivetac, J.A. McCammon, "Elucidating the Inhibition Mechanism of HIV-1 Non-Nucleoside Reverse Mechanism of Inhibitors through Multicopy Molecular Dynamics Simulations", Journal of Molecular Biology, vol. 388 (3), pp. 644- 658, 2008. doi: 10.1016/j.jmb.2009.03.037, PMC 2744402, PMID 19324058.

  • M.P. De Béthune, "Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)", Antiviral Research, vol. 85 (1), pp. 75–90, 2009. doi: 10.1016/j.antiviral.2009.09.008, PMID 19781578.

  • K. Das, P.J. Lewi, S.H. Hughes, E. Arnold, "Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors", Progress in Biophysics & Molecular Biology, vol. 88 (2), pp. 209–231, 2005. doi: 10.1016/j.pbiomolbio.2004.07.001.

  • Noel M O'Boyle1, Michael Banck, Craig A James, Chris Morley, Tim Vandermeersch and Geoffrey R Hutchison, “Open Babel: An open chemical toolbox”, Journal of Cheminformatics, vol. 3:33, 2011.

  • Saba Ferdous, Muhammad Usman Mirza, Usman Saeed. “Docking Studies reveal Phytochemicals as the long searched anticancer drugs for Breast Cancer”. International Journal of Computer Applications (0975 - 8887) Vol. 67 - No. 25, April 2013.

  • S. Rajeswari, S. Kriushnapriya, “Anticancer Activities of Phytochemicals from a Wood Rot Mushroom Phellinus Adamantinus - in Silico and in Vitro Approach”. International Conference on Bioscience, Biochemistry and Bioinformatics IPCBEE vol.5, 2011, IACSIT Press, Singapore.


Abstract Views: 384

PDF Views: 0




  • In Silico Anti-HIV Analysis of FTIR Identified Bioactive Compounds Present in Vitex altissima L and Vitex leucoxylon L

Abstract Views: 384  |  PDF Views: 0

Authors

Santhanabharathi Naganathan
Department of Biotechnology, Vel Tech High Tech Dr. Rangarajan, Dr. Sakunthala Engineering College, Avadi, Chennai, India
Anupama Natarajan
Department of Biotechnology, Vel Tech High Tech Dr. Rangarajan, Dr. Sakunthala Engineering College, Avadi, Chennai, India
P. Vivek
Department of Bio Engineering, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai-600117, India
D. Kesavan
Department of Biotechnology, Vel Tech High Tech Dr. Rangarajan, Dr. Sakunthala Engineering College, Avadi, Chennai, India
S. Ivo Romauld
Department of Bio Engineering, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai-600117, India

Abstract


The knowledge of the traditional plants in India is a collection over millennia by our ancient people. The Siddha System of Medicine (Traditional Tamil System of medicine) is the foremost of all other medical systems in the world which provide service to the humanity for more than 5000 years in combating diseases and also in maintaining its physical, mental and moral health. Vitex species were used in Siddha for its antiviral activity for several years. However, the present study deals with the Human Immunodeficiency Virus because of its complexity and killing effects. FTIR analysis of Vitex altissima L and Vitex leucoxylon L revealed the presence of 21 and 17 bioactive compounds respectively. These compounds were analysed further for its binding affinity mechanism against one of the virulence causing protein, reverse transcriptase (target protein) of Human Immunodeficiency Virus (HIV) by using molecular docking and bioinformatics tools. Interaction rate was determined between bioactive compounds against the protein target based on binding free energy requirements. Molecular docking was also made to the commercially available drugs (Zidovudine, Stavudine, and Nevirapine) against the target protein. By comparing the results, it was clear that the bioactive compounds in the Vitex species were much more effective than the commercially available drugs, thereby suitable for the treatment of AIDS. Hence, this study will form the basis for promoting therapeutic lead molecules from the traditional plants which restore the tradition and also eliminates the harmful side effects.

Keywords


FTIR Analysis, Vitex altissima L, Vitex leucoxylon L, Zidovudine, Stavudine, Nevirapine, Binding Free Energy, Molecular Docking.

References